Article(id=1326652733974754025, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652618341987109, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2025.06.013, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1721145600000, receivedDateStr=2024-07-17, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794228259795, onlineDateStr=2026-11-09, pubDate=1749484800000, pubDateStr=2025-06-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794228259795, onlineIssueDateStr=2026-11-09, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794228259795, creator=13701087609, updateTime=1794228259795, updator=13701087609, issue=Issue{id=1326652618341987109, tenantId=1146029695717560320, journalId=1319690329412173987, year='2025', volume='46', issue='6', pageStart='529', pageEnd='636', issueExtLink='null', onlineDate='null', pubDate='1749484800000', pubDateStr='2025-06-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794228232226, creator='13701087609', updateTime=1794273016466, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1326840457423860645, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652618341987109, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1326840457423860646, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652618341987109, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=612, endPage=620, ext={EN=ArticleExt(id=1326652734197052138, articleId=1326652733974754025, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Meta-analysis of ustekinumab compared with other drugs in second-line treatment for Crohn's disease, columnId=1325221089055486019, journalTitle=World Clinical Drug, columnName=Article, runingTitle=null, highlight=null, articleAbstract=
Objective

To systematically evaluate the efficacy and safety of ustekinumab compared with other second-line drugs for Crohn's disease(CD).

Methods

A systematic search of PubMed, Embase, Cochrane Library, and other databases for cohort studies comparing ustekinumab with other second-line therapies for the treatment of CD. Meta-analysis was performed by Review Manager 5.4 software.

Results

A total of 10 literature studies were included, 1 222 patients in ustekinumab group and 949 patients in other drug groups. The results showed that the clinical remission rate[OR=1.75, 95%CI: (1.38, 2.21), P<0.001], steroid-free clinical remission rate[OR=1.54, 95%CI: (1.17, 2.01),P=0.002] and clinical response rate[OR=2.69, 95%CI: (1.10, 6.58), P=0.030] in ustekinumab group were higher than those of the other drug groups. In addition, the incidence of adverse events[OR=0.29, 95%CI: (0.09, 0.96), P=0.040]and discontinuation rate[OR=0.28, 95%CI: (0.17, 0.46), P<0.001] in ustekinumab group were lower than those of the other drug groups.

Conclusion

Ustekinumab is more effective and safer than the other second-line drugs for CD.

, authors=Chengzheng LIU1, Xingchen WEI1, Gang FANG1, Yu HU1, Jinxi DING1, 2, *, authorsList=Chengzheng LIU, Xingchen WEI, Gang FANG, Yu HU, Jinxi DING, authorCompany=null, correspAuthors=Jinxi DING, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1326652734457098987, articleId=1326652733974754025, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=乌司奴单抗对比其他药物二线治疗克罗恩病的meta分析, columnId=1325221089235841093, journalTitle=世界临床药物, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=
目的

系统评价乌司奴单抗对比其他药物作为二线治疗方案对克罗恩病(Crohn's disease,CD)的疗效和安全性。

方法

计算机检索PubMed、Embase、Cochrane Library等数据库中关于乌司奴单抗对比其他药物二线治疗CD的队列研究,采用Review Manager 5.4软件实施meta分析。

结果

共纳入10项研究,涉及乌司奴单抗组1 222例,其他药物组949例。Meta分析表明,乌司奴单抗组的临床缓解率[OR=1.75,95%CI:(1.38,2.21),P<0.001],无激素临床缓解率[OR=1.54,95%CI:(1.17,2.01),P=0.002]和临床应答率[OR=2.69,95%CI:(1.10,6.58),P=0.030]均高于其他药物组。乌司奴单抗组不良事件发生率[OR=0.29,95%CI:(0.09,0.96),P=0.040]和治疗相关停药率[OR=0.28,95%CI:(0.17,0.46),P<0.001]均低于其他药物组。

结论

作为CD二线治疗选择,乌司奴单抗在疗效和安全性方面均优于其他同类药物。

, authors=刘成正1, 卫星辰1, 方刚1, 胡宇1, 丁锦希1, 2, *, authorsList=刘成正, 卫星辰, 方刚, 胡宇, 丁锦希, authorCompany=null, correspAuthors=丁锦希, authorNote=

刘成正,硕士研究生,研究方向:药物经济评价。

, correspAuthorsNote=
丁锦希,教授,博士生导师,研究方向:医药政策法规、医药市场准入与药物经济学。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=HmX+3T0xBmiR6JSPpsYKNQ==, magXml=6SK0vk921JVwbJIIiq2Mpg==, pdfUrl=null, pdf=s7KbK8O6ANq4c5H/DV/ncg==, pdfFileSize=1238191, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=2Suh0q27sPSgcLafTO40pA==, mapNumber=null, fund=null)}, authors=[Author(id=1326652734834586355, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652734918472437, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, authorId=1326652734834586355, language=EN, stringName=Chengzheng LIU, firstName=Chengzheng, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652734981386998, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, authorId=1326652734834586355, language=CN, stringName=刘成正, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国药科大学国际医药商学院,江苏 南京 211198, bio={"content":"

刘成正,硕士研究生,研究方向:药物经济评价。

"}, bioImg=null, bioContent=

刘成正,硕士研究生,研究方向:药物经济评价。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652734679397100, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, xref=1., ext=[AuthorCompanyExt(id=1326652734687785709, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1326652734696174318, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)])]), Author(id=1326652735044301560, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652735132381946, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, authorId=1326652735044301560, language=EN, stringName=Xingchen WEI, firstName=Xingchen, middleName=null, lastName=WEI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652735199490811, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, authorId=1326652735044301560, language=CN, stringName=卫星辰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国药科大学国际医药商学院,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652734679397100, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, xref=1., ext=[AuthorCompanyExt(id=1326652734687785709, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1326652734696174318, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)])]), Author(id=1326652735358874365, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652735472120575, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, authorId=1326652735358874365, language=EN, stringName=Gang FANG, firstName=Gang, middleName=null, lastName=FANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652735543423744, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, authorId=1326652735358874365, language=CN, stringName=方刚, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国药科大学国际医药商学院,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652734679397100, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, xref=1., ext=[AuthorCompanyExt(id=1326652734687785709, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1326652734696174318, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)])]), Author(id=1326652735623115522, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652735790887684, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, authorId=1326652735623115522, language=EN, stringName=Yu HU, firstName=Yu, middleName=null, lastName=HU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652735887356677, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, authorId=1326652735623115522, language=CN, stringName=胡宇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国药科大学国际医药商学院,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652734679397100, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, xref=1., ext=[AuthorCompanyExt(id=1326652734687785709, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1326652734696174318, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)])]), Author(id=1326652736063517447, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326652736164180746, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, authorId=1326652736063517447, language=EN, stringName=Jinxi DING, firstName=Jinxi, middleName=null, lastName=DING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652736222901003, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, authorId=1326652736063517447, language=CN, stringName=丁锦希, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国药科大学国际医药商学院,江苏 南京 211198
2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652734679397100, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, xref=1., ext=[AuthorCompanyExt(id=1326652734687785709, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1326652734696174318, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1326652734746505967, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, xref=2., ext=[AuthorCompanyExt(id=1326652734754894576, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734746505967, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1326652734763283185, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734746505967, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])])], keywords=[Keyword(id=1326652736336147212, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, language=EN, orderNo=1, keyword=ustekinumab), Keyword(id=1326652738026451725, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, language=EN, orderNo=2, keyword=second-line threatment), Keyword(id=1326652738110337806, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, language=EN, orderNo=3, keyword=Crohn's disease), Keyword(id=1326652738190029583, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, language=EN, orderNo=4, keyword=meta-analysis), Keyword(id=1326652738320053008, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, language=CN, orderNo=1, keyword=乌司奴单抗), Keyword(id=1326652738387161873, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, language=CN, orderNo=2, keyword=二线治疗), Keyword(id=1326652738471047954, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, language=CN, orderNo=3, keyword=克罗恩病), Keyword(id=1326652738533962515, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, language=CN, orderNo=4, keyword=meta分析)], refs=[Reference(id=1326652738651403028, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=BAUMGART DC, SANDBORN WJ. Crohn's disease[J].Lancet, 2012, 380(9853): 1590-1605., articleTitle=null, refAbstract=null), Reference(id=1326652738726900501, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=DANESE S, FIOCCHI C. Etiopathogenesis of inflammatory bowel diseases[J]. World J Gastroenterol, 2006, 12(30):4807-4812., articleTitle=null, refAbstract=null), Reference(id=1326652738810786582, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=李学锋, 彭霞, 周明欢. 我国炎症性肠病流行病学研究进展[J]. 现代消化及介入诊疗, 2020, 25(9): 1265-1267., articleTitle=null, refAbstract=null), Reference(id=1326652738882089751, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=TORRES J, BONOVAS S, DOHERTY G, et al. ECCO guidelines on therapeutics in Crohn's disease: medical treatment[J]. J Crohns Colitis, 2020, 14(1): 4-22., articleTitle=null, refAbstract=null), Reference(id=1326652738940810008, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=宋阿倩, 周秀彦. 乌司奴单抗在治疗克罗恩病中的作用机制[J]. 胃肠病学和肝病学杂志, 2021, 30(8): 946-949., articleTitle=null, refAbstract=null), Reference(id=1326652739007918873, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=ARENCIBIA AC, FERRER CS, CORDON JP, et al. What is the best strategy after failure to anti-TNF? Ustekinumab or other anti-TNF?[J]. J Crohn's Colitis, 2020, 14(S1): S554., articleTitle=null, refAbstract=null), Reference(id=1326652739062444826, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=TOWNSEND T, RAZANSKAITE V, DODD S, et al.Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti-TNF-refractory Crohn's disease[J]. Aliment Pharmacol Ther. 2020, 52(8):1341-1352., articleTitle=null, refAbstract=null), Reference(id=1326652739121165083, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=BIEMANS VBC, van der WOUDE CJ, DIJKSTRA G, et al. Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment[J]. Aliment Pharmacol Ther, 2020, 52(1): 123-134., articleTitle=null, refAbstract=null), Reference(id=1326652739188273948, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=ALRIC H, AMIOT A, KIRCHGESNER J, et al. The effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor[J]. Aliment Pharmacol Ther, 2020, 51(10):948-957., articleTitle=null, refAbstract=null), Reference(id=1326652739246994205, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=MANLAY L, BOSCHETTI G, PEREIRA B, et al.Comparison of short- and long-term effectiveness between ustekinumab and vedolizumab in patients with Crohn's disease refractory to anti-tumour necrosis factor therapy[J].Aliment Pharmacol Ther, 2021, 53(12): 1289-1299., articleTitle=null, refAbstract=null), Reference(id=1326652739305714462, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=RAYER C, NACHURY M, BOURREILLE A, et al. Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study[J]. Bio Med Central Gastroenterol, 2022, 22(1): 498., articleTitle=null, refAbstract=null), Reference(id=1326652739381211935, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=HYUN HK, ZHANG HS, YU J, et al. Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn's disease in patients with prior failure of anti-tumour necrosis factor treatment[J]. Bio Med Central Gastroenterol, 2022, 22(1):143., articleTitle=null, refAbstract=null), Reference(id=1326652739456709408, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=BACSUR P, MATUZ M, RESAL T, et al. Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn's disease: results from a multicentre cohort study[J]. Therap Adv Gastroenterol, 2022, 15: 2236-2261., articleTitle=null, refAbstract=null), Reference(id=1326652739523818273, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=ONALI S, PUGLIESE D, CAPRIOLI FA, et al. An objective comparison of vedolizumab and ustekinumab effectiveness in Crohn's disease patients' failure to TNF-α inhibitors[J]. Am J Gastroenterol, 2022, 117(8): 1279-1287., articleTitle=null, refAbstract=null), Reference(id=1326652739607704354, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=YANG H, HUANG Z, LI M, et al. Comparative effectiveness of ustekinumab vs. vedolizumab for anti-TNF-naïve or anti-TNF-exposed Crohn's disease: a multicenter cohort study[J].EClinicalMedicine, 2023, 66: 102337., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1326652734679397100, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, xref=1., ext=[AuthorCompanyExt(id=1326652734687785709, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1326652734696174318, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1326652734746505967, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, xref=2., ext=[AuthorCompanyExt(id=1326652734754894576, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734746505967, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1326652734763283185, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734746505967, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.06.013, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.06.013, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2025.06.013, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2025.06.013, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1749484800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
乌司奴单抗对比其他药物二线治疗克罗恩病的meta分析
刘成正 1 , 卫星辰 1 , 方刚 1 , 胡宇 1 , 丁锦希 1, 2, *
世界临床药物 | 研究论文 2025,46(6): 612-620
收起
收藏切换
世界临床药物 |研究论文 2025 , 46 (6) : 612 -620
乌司奴单抗对比其他药物二线治疗克罗恩病的meta分析
全屏
[Author(id=1326652734834586355, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652734918472437, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, authorId=1326652734834586355, language=EN, stringName=Chengzheng LIU, firstName=Chengzheng, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652734981386998, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, authorId=1326652734834586355, language=CN, stringName=刘成正, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国药科大学国际医药商学院,江苏 南京 211198, bio={"content":"

刘成正,硕士研究生,研究方向:药物经济评价。

"}, bioImg=null, bioContent=

刘成正,硕士研究生,研究方向:药物经济评价。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652734679397100, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, xref=1., ext=[AuthorCompanyExt(id=1326652734687785709, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1326652734696174318, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)])]), Author(id=1326652735044301560, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652735132381946, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, authorId=1326652735044301560, language=EN, stringName=Xingchen WEI, firstName=Xingchen, middleName=null, lastName=WEI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652735199490811, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, authorId=1326652735044301560, language=CN, stringName=卫星辰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国药科大学国际医药商学院,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652734679397100, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, xref=1., ext=[AuthorCompanyExt(id=1326652734687785709, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1326652734696174318, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)])]), Author(id=1326652735358874365, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652735472120575, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, authorId=1326652735358874365, language=EN, stringName=Gang FANG, firstName=Gang, middleName=null, lastName=FANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652735543423744, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, authorId=1326652735358874365, language=CN, stringName=方刚, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国药科大学国际医药商学院,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652734679397100, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, xref=1., ext=[AuthorCompanyExt(id=1326652734687785709, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1326652734696174318, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)])]), Author(id=1326652735623115522, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652735790887684, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, authorId=1326652735623115522, language=EN, stringName=Yu HU, firstName=Yu, middleName=null, lastName=HU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652735887356677, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, authorId=1326652735623115522, language=CN, stringName=胡宇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国药科大学国际医药商学院,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652734679397100, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, xref=1., ext=[AuthorCompanyExt(id=1326652734687785709, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1326652734696174318, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)])]), Author(id=1326652736063517447, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326652736164180746, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, authorId=1326652736063517447, language=EN, stringName=Jinxi DING, firstName=Jinxi, middleName=null, lastName=DING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652736222901003, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, authorId=1326652736063517447, language=CN, stringName=丁锦希, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国药科大学国际医药商学院,江苏 南京 211198
2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652734679397100, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, xref=1., ext=[AuthorCompanyExt(id=1326652734687785709, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1326652734696174318, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734679397100, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1326652734746505967, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, xref=2., ext=[AuthorCompanyExt(id=1326652734754894576, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734746505967, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1326652734763283185, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652733974754025, companyId=1326652734746505967, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])])]
刘成正1, 卫星辰1, 方刚1, 胡宇1, 丁锦希1, 2, *
作者信息
  • 1.中国药科大学国际医药商学院,江苏 南京 211198
  • 2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198
通讯作者:
丁锦希,教授,博士生导师,研究方向:医药政策法规、医药市场准入与药物经济学。
作者简介:

刘成正,硕士研究生,研究方向:药物经济评价。

Meta-analysis of ustekinumab compared with other drugs in second-line treatment for Crohn's disease
Chengzheng LIU1, Xingchen WEI1, Gang FANG1, Yu HU1, Jinxi DING1, 2, *
Affiliations
  • 1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
  • 2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
出版时间: 2025-06-10 doi: 10.13683/j.wph.2025.06.013
文章导航
收藏切换
目的

系统评价乌司奴单抗对比其他药物作为二线治疗方案对克罗恩病(Crohn's disease,CD)的疗效和安全性。

方法

计算机检索PubMed、Embase、Cochrane Library等数据库中关于乌司奴单抗对比其他药物二线治疗CD的队列研究,采用Review Manager 5.4软件实施meta分析。

结果

共纳入10项研究,涉及乌司奴单抗组1 222例,其他药物组949例。Meta分析表明,乌司奴单抗组的临床缓解率[OR=1.75,95%CI:(1.38,2.21),P<0.001],无激素临床缓解率[OR=1.54,95%CI:(1.17,2.01),P=0.002]和临床应答率[OR=2.69,95%CI:(1.10,6.58),P=0.030]均高于其他药物组。乌司奴单抗组不良事件发生率[OR=0.29,95%CI:(0.09,0.96),P=0.040]和治疗相关停药率[OR=0.28,95%CI:(0.17,0.46),P<0.001]均低于其他药物组。

结论

作为CD二线治疗选择,乌司奴单抗在疗效和安全性方面均优于其他同类药物。

乌司奴单抗  /  二线治疗  /  克罗恩病  /  meta分析
Objective

To systematically evaluate the efficacy and safety of ustekinumab compared with other second-line drugs for Crohn's disease(CD).

Methods

A systematic search of PubMed, Embase, Cochrane Library, and other databases for cohort studies comparing ustekinumab with other second-line therapies for the treatment of CD. Meta-analysis was performed by Review Manager 5.4 software.

Results

A total of 10 literature studies were included, 1 222 patients in ustekinumab group and 949 patients in other drug groups. The results showed that the clinical remission rate[OR=1.75, 95%CI: (1.38, 2.21), P<0.001], steroid-free clinical remission rate[OR=1.54, 95%CI: (1.17, 2.01),P=0.002] and clinical response rate[OR=2.69, 95%CI: (1.10, 6.58), P=0.030] in ustekinumab group were higher than those of the other drug groups. In addition, the incidence of adverse events[OR=0.29, 95%CI: (0.09, 0.96), P=0.040]and discontinuation rate[OR=0.28, 95%CI: (0.17, 0.46), P<0.001] in ustekinumab group were lower than those of the other drug groups.

Conclusion

Ustekinumab is more effective and safer than the other second-line drugs for CD.

ustekinumab  /  second-line threatment  /  Crohn's disease  /  meta-analysis
刘成正, 卫星辰, 方刚, 胡宇, 丁锦希. 乌司奴单抗对比其他药物二线治疗克罗恩病的meta分析. 世界临床药物, 2025 , 46 (6) : 612 -620 . DOI: 10.13683/j.wph.2025.06.013
Chengzheng LIU, Xingchen WEI, Gang FANG, Yu HU, Jinxi DING. Meta-analysis of ustekinumab compared with other drugs in second-line treatment for Crohn's disease[J]. World Clinical Drug, 2025 , 46 (6) : 612 -620 . DOI: 10.13683/j.wph.2025.06.013

参考文献 引证文献
排序方式:
[1]
BAUMGART DC, SANDBORN WJ. Crohn's disease[J].Lancet, 2012, 380(9853): 1590-1605.
[2]
DANESE S, FIOCCHI C. Etiopathogenesis of inflammatory bowel diseases[J]. World J Gastroenterol, 2006, 12(30):4807-4812.
[3]
李学锋, 彭霞, 周明欢. 我国炎症性肠病流行病学研究进展[J]. 现代消化及介入诊疗, 2020, 25(9): 1265-1267.
[4]
TORRES J, BONOVAS S, DOHERTY G, et al. ECCO guidelines on therapeutics in Crohn's disease: medical treatment[J]. J Crohns Colitis, 2020, 14(1): 4-22.
[5]
宋阿倩, 周秀彦. 乌司奴单抗在治疗克罗恩病中的作用机制[J]. 胃肠病学和肝病学杂志, 2021, 30(8): 946-949.
[6]
ARENCIBIA AC, FERRER CS, CORDON JP, et al. What is the best strategy after failure to anti-TNF? Ustekinumab or other anti-TNF?[J]. J Crohn's Colitis, 2020, 14(S1): S554.
[7]
TOWNSEND T, RAZANSKAITE V, DODD S, et al.Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti-TNF-refractory Crohn's disease[J]. Aliment Pharmacol Ther. 2020, 52(8):1341-1352.
[8]
BIEMANS VBC, van der WOUDE CJ, DIJKSTRA G, et al. Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment[J]. Aliment Pharmacol Ther, 2020, 52(1): 123-134.
[9]
ALRIC H, AMIOT A, KIRCHGESNER J, et al. The effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor[J]. Aliment Pharmacol Ther, 2020, 51(10):948-957.
[10]
MANLAY L, BOSCHETTI G, PEREIRA B, et al.Comparison of short- and long-term effectiveness between ustekinumab and vedolizumab in patients with Crohn's disease refractory to anti-tumour necrosis factor therapy[J].Aliment Pharmacol Ther, 2021, 53(12): 1289-1299.
[11]
RAYER C, NACHURY M, BOURREILLE A, et al. Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study[J]. Bio Med Central Gastroenterol, 2022, 22(1): 498.
[12]
HYUN HK, ZHANG HS, YU J, et al. Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn's disease in patients with prior failure of anti-tumour necrosis factor treatment[J]. Bio Med Central Gastroenterol, 2022, 22(1):143.
[13]
BACSUR P, MATUZ M, RESAL T, et al. Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn's disease: results from a multicentre cohort study[J]. Therap Adv Gastroenterol, 2022, 15: 2236-2261.
[14]
ONALI S, PUGLIESE D, CAPRIOLI FA, et al. An objective comparison of vedolizumab and ustekinumab effectiveness in Crohn's disease patients' failure to TNF-α inhibitors[J]. Am J Gastroenterol, 2022, 117(8): 1279-1287.
[15]
YANG H, HUANG Z, LI M, et al. Comparative effectiveness of ustekinumab vs. vedolizumab for anti-TNF-naïve or anti-TNF-exposed Crohn's disease: a multicenter cohort study[J].EClinicalMedicine, 2023, 66: 102337.
2025年第46卷第6期
47
10
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2025.06.013
  • 接收时间:2024-07-17
  • 首发时间:2026-11-09
  • 出版时间:2025-06-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-07-17
基金
作者信息
    1.中国药科大学国际医药商学院,江苏 南京 211198
    2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198

通讯作者:

丁锦希,教授,博士生导师,研究方向:医药政策法规、医药市场准入与药物经济学。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.06.013
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏